STING1 and neoplasm: The current paradigm proposes that OV tumor cell killing induces immunologic cell death which triggers innate responses through exogenous genome-sensing pathways such as Toll like receptors (TLRs) and the STING/cGAS pathway, culminating in the priming and expansion of an adaptive antitumor T cell response1–4.